These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study. Giusti M, Cecoli F, Fazzuoli L, De Franchis V, Ceresola E, Ferone D, Mussap M, Minuto F. Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547 [Abstract] [Full Text] [Related]
6. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G. Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [Abstract] [Full Text] [Related]
7. The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea. Keating FR, Jones JD, Elveback LR, Randall RV. J Lab Clin Med; 1969 May; 73(5):825-34. PubMed ID: 5779266 [No Abstract] [Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288 [Abstract] [Full Text] [Related]
14. Radioiodine-labeled proteins in the serum of patients treated with 131I for thyroid disease. Valenta L. Endocrinol Exp; 1971 Jun; 5(3):127-42. PubMed ID: 5005942 [No Abstract] [Full Text] [Related]